IDT biologika base award FY20 master cell banks manufacturing for pandemic preparedness covid 19 can 844363 $20,462.00
Ended Awarded Last action
- Contract number
- 75N93020F00002
- Awardee
-
IDT Biologika GMBH UEI E14GD5J873N9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $554,341
Award facts
- Contract value 100% obligated
- $554,341.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Fixed Price Level of Effort
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$7,748 | |
| Terminate for Convenience | $0 | |
| Funding Only Action | $541,627 | |
| Original award | $20,462 |
About this award
This is a fixed-price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to IDT Biologika GMBH, a German biotechnology company. The contract is for the manufacturing of master cell banks to support COVID-19 pandemic preparedness efforts. The base award is for $20,462.00, with a total potential ceiling value of $554,341.00. The contract has an ultimate completion date of May 17, 2025, and does not have a set-aside designation. IDT Biologika GMBH is a foreign-owned, for-profit organization that specializes in contract manufacturing of various biological products, including vaccines and viral vectors, for pharmaceutical and biotech clients.
Quick answers
Who was awarded contract 75N93020F00002?
75N93020F00002 was awarded to IDT Biologika GMBH by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 8, 2020.
How much is contract 75N93020F00002 worth?
The government has obligated $554,341 on 75N93020F00002.
Is contract 75N93020F00002 an order under another contract?
Yes. 75N93020F00002 is a delivery order under 75N93018D00011, an indefinite delivery contract.
Was contract 75N93020F00002 competed?
The extent of competition for 75N93020F00002 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award